Molecular basis of inverse agonism in a G protein-coupled receptor

被引:119
作者
Vilardaga, JP
Steinmeyer, R
Harms, GS
Lohse, MJ
机构
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany
[2] Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany
关键词
D O I
10.1038/nchembio705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G protein-coupled receptors (GPCRs) recognize a wide variety of extracellular ligands to control diverse physiological processes. Compounds that bind to such receptors can either stimulate, fully or partially (full or partial agonists), or reduce (inverse agonists) the receptors' basal activity and receptor-mediated signaling. Various studies have shown that the activation of receptors through binding of agonists proceeds by conformational changes as the receptor switches from a resting to an active state leading to G protein signaling(1-5). Yet the molecular basis for differences between agonists and inverse agonists is unclear. These different classes of compounds are assumed to switch the receptors' conformation in distinct ways. It is not known, however, whether such switching occurs along a linear 'on-off' scale or whether agonists and inverse agonists induce different switch mechanisms. Using a fluorescence-based approach to study the alpha(2A)-adrenergic receptor (alpha(2A)AR), we show that inverse agonists are differentiated from agonists in that they trigger a very distinct mode of a receptor's switch. This switch couples inverse agonist binding to the suppression of activity in the receptor.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 16 条
[1]   Activation and deactivation kinetics of α2A- and α2C-adrenergic receptor-activated G protein-activated inwardly rectifying K+ channel currents [J].
Bünemann, M ;
Bücheler, MM ;
Philipp, M ;
Lohse, MJ ;
Hein, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :47512-47517
[2]   Simultaneous dual-color and dual-polarization imaging of single molecules [J].
Cognet, L ;
Harms, GS ;
Blab, GA ;
Lommerse, PHM ;
Schmidt, T .
APPLIED PHYSICS LETTERS, 2000, 77 (24) :4052-4054
[3]  
DELIGHT RAF, 2003, BRIT J PHARMACOL, V130, P1
[4]  
GETHER U, 1995, J BIOL CHEM, V270, P28268
[5]   Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor [J].
Ghanouni, P ;
Steenhuis, JJ ;
Farrens, DL ;
Kobilka, BK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) :5997-6002
[6]   Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor [J].
Ghanouni, P ;
Gryczynski, Z ;
Steenhuis, JJ ;
Lee, TW ;
Farrens, DL ;
Lakowicz, JR ;
Kobilka, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24433-24436
[7]   Molecular spectroscopy and dynamics of intrinsically fluorescent proteins: Coral red (dsRed) and yellow (Citrine) [J].
Heikal, AA ;
Hess, ST ;
Baird, GS ;
Tsien, RY ;
Webb, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :11996-12001
[8]   Efficacy as a vector: the relative prevalence and paucity of inverse agonism [J].
Kenakin, T .
MOLECULAR PHARMACOLOGY, 2004, 65 (01) :2-11
[9]  
REN Q, 1993, J BIOL CHEM, V268, P16483
[10]   An improved cyan fluorescent protein variant useful for FRET [J].
Rizzo, MA ;
Springer, GH ;
Granada, B ;
Piston, DW .
NATURE BIOTECHNOLOGY, 2004, 22 (04) :445-449